Pharmaceutical Industry in Vietnam: Sluggish Sector in a Growing Market.

Vietnam is a fast growing economy in the Asian region with a significantly high population (over 92 million in 2015). Although still expanding (about ...
2MB Sizes 3 Downloads 9 Views

Recommend Documents


Drug repurposing in pharmaceutical industry and its impact on market access: market access implications.
Drug repurposing is a group of development strategies employed in order to overcome some of the hurdles innate to drug research and development. Drug repurposing includes drug repositioning, reformulation and combination.

Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications.
Repurposing has become a mainstream strategy in drug development, but it faces multiple challenges, amongst them the increasing and ever changing regulatory framework. This is the second study of a series of three-part publication project with the ul

Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature.
Medicinal products that have been developed and approved for one disease may be the object of additional clinical development in other disease areas or of additional pharmaceutical development for new and different formulations. The newly developed p

Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical market.
Pharmaceutical industry is knowledge-intensive and highly globalized, in both developed and developing countries. On the other hand, if companies want to survive, they should be able to compete well in both domestic and international markets. The mai

Quality in the pharmaceutical industry - A literature review.
The aim of this study is to:a.Highlight the most important guidelines and practices of quality in the pharmaceutical industry.b.Organize such guidelines and practices to create a guide to pave the way for other researchers who would like to dig deepe

New drug regulations in France: what are the impacts on market access? Part 2 - impacts on market access and impacts for the pharmaceutical industry.
Access to the French drug market is being impacted by an ongoing dramatic shift in practice as well as by two laws that came into force in December 2011. This new environment has been described and analyzed in two separate articles. This second artic